SCHEMBL17295520

SCHEMBL17295520

O=C1C(=Cc2ccc3[nH]cnc3c2)SC(=NCc2cccnc2)N1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.49
▸ MAPT P10636 3/20 0.49
▸ NPSR1 Q6W5P4 3/20 0.49
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ S1PR1 P21453 12/20 0.44
▸ S1PR3 Q99500 12/20 0.44
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HPGD P15428 2/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ DYRK3 O43781 1/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ CLK2 P49760 1/20 0.40
▸ CLK3 P49761 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ DYRK2 Q92630 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ DYRK4 Q9NR20 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295518 1.00 ALDH1A1 (0.49) ALDH1A1MAPTNPSR1LMNAHTT
SCHEMBL17295639 0.92 S1PR1 (0.48) ALDH1A1MAPTNPSR1LMNAHTT
SCHEMBL17295641 0.92 S1PR1 (0.48) ALDH1A1MAPTNPSR1LMNAHTT
SCHEMBL17295527 0.86 S1PR1 (0.45) ALDH1A1MAPTNPSR1S1PR1S1PR3
SCHEMBL17295428 0.86 FAAH (0.44) ALDH1A1MAPTNPSR1LMNAHTT
SCHEMBL17295529 0.86 S1PR1 (0.45) ALDH1A1MAPTNPSR1S1PR1S1PR3
SCHEMBL17295426 0.86 FAAH (0.44) ALDH1A1MAPTNPSR1LMNAHTT
SCHEMBL17295263 0.85 S1PR1 (0.50) ALDH1A1NPSR1S1PR1S1PR3MEN1
SCHEMBL17295264 0.85 S1PR1 (0.50) ALDH1A1NPSR1S1PR1S1PR3MEN1
SCHEMBL17295290 0.84 S1PR1 (0.50) ALDH1A1MAPTNPSR1S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback